Simulations Plus (NASDAQ:SLP – Get Free Report) posted its earnings results on Thursday. The technology company reported $0.30 earnings per share for the quarter, topping analysts’ consensus estimates of $0.23 by $0.07, FiscalAI reports. The firm had revenue of $21.89 million for the quarter, compared to the consensus estimate of $20.90 million. Simulations Plus had a negative net margin of 77.96% and a positive return on equity of 16.21%.
Simulations Plus Price Performance
SLP opened at $18.34 on Friday. The business’s 50-day moving average is $16.47 and its two-hundred day moving average is $15.47. Simulations Plus has a 1 year low of $11.09 and a 1 year high of $21.01. The firm has a market capitalization of $370.47 million, a PE ratio of -5.86 and a beta of 1.30.
Insider Activity
In related news, Director Walter S. Woltosz sold 4,177 shares of the stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $18.44, for a total transaction of $77,023.88. Following the completion of the sale, the director owned 3,202,131 shares of the company’s stock, valued at $59,047,295.64. This represents a 0.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 6,177 shares of company stock valued at $108,754. 19.10% of the stock is owned by insiders.
Institutional Inflows and Outflows
Analysts Set New Price Targets
Several research firms recently commented on SLP. William Blair lowered Simulations Plus from an “outperform” rating to a “market perform” rating in a research report on Wednesday, June 17th. Wall Street Zen downgraded Simulations Plus from a “buy” rating to a “hold” rating in a research report on Saturday, June 13th. Craig Hallum cut shares of Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 price target for the company. in a research note on Thursday, June 18th. Weiss Ratings raised shares of Simulations Plus from a “sell (d-)” rating to a “sell (d)” rating in a research note on Friday, June 5th. Finally, TD Cowen cut their price objective on Simulations Plus from $19.00 to $16.00 and set a “hold” rating on the stock in a research report on Friday, April 10th. One research analyst has rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $19.88.
View Our Latest Stock Analysis on SLP
About Simulations Plus
Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.
Featured Stories
- Five stocks we like better than Simulations Plus
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.
